Monthly Archives: April 2002


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 29, 2002 China Daily: Harvard Project ViolatesFarmers’ Rights FYI American experiments on impoverished populations inunderdeveloped countries needs much more oversight than seems to have beenprovided. XIONG […]

InfoMail for April 29, 2002


Current federal regulations set no limits on the level of risk that a competent adult may voluntarily choose to undertake for the sake of science. The regulations require prior approval by a review board (IRB) to ensure the research meets scientific and ethical justification, to ensure that the risks and benefits (if any) are fully disclosed to the subject, and that the subject can exercise the right to give or withhold informed consent.

Protecting Human Subjects in Research: Are Current Safeguards Adequate?


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 22, 2002 ScientificMisconduct Notices FYI Scientific misconduct is a big problem undermining theintegrity of the scientific literature. Data falsification leads others toerroneous conclusions that may have […]

InfoMail for April 22, 2002



Abortion Pill Tested in clinical Trials for Severe Depression_NYT Mon, 28 Oct 2002 The New York Times reported that Corcept Therapeutics is testing the controversial abortion pill, Mifepristone (formerly known as RU-486, brand name, Mifreprex), in clinical trials for the treatment of severe depression. The article uncritically transcribed the sponsors’ […]

Abortion Pill Tested in clinical Trials for Severe Depression – ...


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 19, 2002 DHHS / FDA flip-flopsecond time re: " pediatric rule" FYI Tommy Thompson, Secretary of The Department of Health andHuman Services has reversed the FDA’s […]

InfoMail for April 19, 2002


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 17, 2002 Scandal: Scientists Take Cash forGhostwritten Papers FYI The pharmaceutical industry has gained unprecedentedcontrol over research data. The published papers ended up being written byghostwriters–company […]

InfoMail for April 17, 2002



  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 16, 2002 Do Risk Factors NecessarilyLead to Disease? FYI Dr. Peter Gotzsche, who touched off a firestorm when hechallenged the assumption that early detection of a […]

InfoMail for April 16, 2002


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 15, 2002 Bill Would Enable Californians to Earn Easy Money by Consigning Relatives toMedical Experimentation FYI A bill has been introduced in the California StateAssembly, AB […]

InfoMail for April 15, 2002


  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 14, 2002Clinical Trials Given "At Your Own Risk" FYI TIME Magazine’s cover story, "At Your Own Risk,"(excerpts below) focuses on several high profile research scandals that […]

InfoMail for April 13, 2002



  AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav April 12, 2002 If Placebo Works Without Risk,Side-Effects or Cost — Why Prescribe Anti-Depressant Drugs? FYI As we reported in yesterday’s Infomail, a major governmentfunded study found […]

InfoMail for April 12, 2002